Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amer Sports Inc (AS) vs Zoetis Inc (ZTS) Price & Performance

Amer Sports IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Amer Sports Inc vs Zoetis Inc — how do they compare? Amer Sports Inc trades at $33.21 (market cap $19.69B), while Zoetis Inc trades at $73.38 (market cap $31.14B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays a 2.81% dividend while Amer Sports Inc pays none. Which is the better fit depends on your goals.

ASZTS
Market Cap
$19.69B$31.14B
Sector
TechnologyHealth
52-Week High
$41.96$156.76
52-Week Low
$29.54$71.91
Enterprise Value
$20.01B$38.70B
Dividend Yield
2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amer Sports Inc

Amer Sports (AS) trades at $33.47, down 7.46% over 24 hours amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $0.38 surpassing expectations. Revenue growth remains strong at 32% year-over-year in Q1 2026, and the company raised its full-year guidance. Analyst consensus is overwhelmingly bullish with a $58.67 price target, though technical indicators suggest near-term weakness.

The outlook is positive given robust fundamentals and upward earnings revisions, but risks include execution on growth targets and market volatility. The current price presents a potential entry point relative to analyst targets, though investors should monitor the upcoming Q2 2026 earnings report on August 18, 2026, for confirmation of continued momentum.

Zoetis Inc

Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.

The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.

Returns comparison

Trailing returns across standard periods

About Amer Sports Inc

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.

Read more on AS

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS